Ignite Creation Date:
2025-12-25 @ 2:20 AM
Ignite Modification Date:
2026-03-22 @ 3:20 PM
Study NCT ID:
NCT06129734
Status:
RECRUITING
Last Update Posted:
2025-08-26
First Post:
2023-11-08
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant
Sponsor:
Benjamin Tomlinson
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE2923
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None